The lung-cell type that's most susceptible to infection by SARS-CoV-2, the virus that causes COVID-19, is not the one previously assumed to be most vulnerable. What's more, the virus enters this susceptible cell via an unexpected ...
Apr 10, 2024
0
91
A research team led by the United States Army Medical Research Institute of Infectious Diseases, or USAMRIID, that includes Scott Pegan at the UC Riverside School of Medicine has discovered an important protective antibody ...
Mar 26, 2024
0
52
Two progressively degenerative diseases, amyotrophic lateral sclerosis (ALS, commonly known as Lou Gehrig's disease) and frontotemporal dementia (FTD, recently in the news with the diagnoses of actor Bruce Willis and talk ...
Mar 18, 2024
0
131
Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this ...
Mar 12, 2024
0
101
The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended, according to new research from UC San Francisco that offers potential clues to why some ...
Mar 7, 2024
0
597
A new study led by the University of Oxford has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more. The findings have been published in the ...
Feb 21, 2024
0
27
Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have built and demonstrated the potential efficacy of a new chimeric antigen receptor (CAR) T-cell-based immunotherapy specifically designed to treat patients ...
Feb 16, 2024
0
65
Findings from a new study conducted by a team of researchers at Dartmouth's Geisel School of Medicine and Thayer School of Engineering and published in Cell Reports Medicine offer new insights into how antibodies function ...
Feb 12, 2024
0
66
Pancreatic cancer can be a devastating diagnosis due to its extremely aggressive nature and low survival rate. But there may be hope on the horizon thanks to scientists at RUSH who have discovered two new targets for decreasing ...
Feb 1, 2024
0
25
Compounds that obstruct the "landing gear" of a range of harmful viruses can successfully protect against infection by the virus that causes COVID-19, a study led by Dana-Farber Cancer Institute scientists shows. Based on ...
Jan 5, 2024
0
125
